Prostaglandin D2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells

Circulation Research

Volumn 82, Issue 2, 1998, Pages 204-209

  Nagoshi, Hiroshi ^a   Uehara, Yoshio ^a   Kanai, Fumihiko ^a   Maeda, Shin ^a   Ogura, Tsutomu ^b   Goto, Atsuo ^a   Toyo oka, Teruhiko ^a   Esurni, Hiroyasu ^b   Shimizu, Takao ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Expression inhibition; Inducible nitric oxide synthase; Prostaglandin D2; Prostaglandin J2; Vascular smooth muscle cells

Indexed keywords

CARBACYCLIN; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN D2; PROSTAGLANDIN J2; CYTOKINE; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; NOS2 PROTEIN, RAT; PROSTAGLANDIN;

ANIMAL CELL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; ENZYME INDUCTION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; IMMUNOBLOTTING; INFLAMMATION; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; WISTAR KYOTO RAT;

ANIMALS; CELLS, CULTURED; CYTOKINES; ENZYME INDUCTION; ENZYME INHIBITORS; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN D2; PROSTAGLANDINS; RATS; RATS, INBRED WKY; RNA, MESSENGER;

EID: 0032498334     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.2.204     Document Type: Article

References (38)

1. Moncada S, Palmer R, Higgs E. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
2. Minor RL, Myers PR, Guerra R, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1990;86:2109-2116.
3. Sobey CG, Brooks RM, Heistad DD. Evidence that expression of inducible nitric oxide synthase in response to endotoxin is augmented in atherosclerotic rabbits. Circ Res. 1995;77:536-554.
4. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 1991;338:1557-1558.
5. Joly GA, Sehini VB, Vanhoutte PM. Balloon injury and interleukin-1β induce nitric oxide synthase activity in rat carotid arteries. Circ Res. 1992; 71:331-338.
6. Tsukada T, Rosenfeld M, Ross R, Gown AM. Immunocytochemical analysis of cellular components in lesions of atherosclerosis of the Watanabe and fat-fed rabbit using monoclonal antibodies. Arteriosclerosis. 1986;6:601-613.
7. Bernard C, Szekely B, Philip I, Wollman E, Payen D, Tedgui A. Activated macrophages depress the contractility of rabbit carotids via an L-arginine/ nitric oxide-dependent effector mechanism: connection with amplified cytokine release. J Clin Invest. 1992;89:851-860.
8. 2 production is likely antigen-presenting cells: localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. J Immunol. 1989;143:2982-2989.
9. 2: differential sensitivity of platelet transduction processes and functional response to inhibition by cyclic AMP. Biochem J. 1985;232:267-271.
10. 2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation. Circ Res. 1992;71:1305-1313.
11. 2, a cerebral sleep-inducing substance in monkey. Proc Natl Acad Sci U S A. 1988;85:4082-4086.
12. 2: anti-tumor and anti-viral activities and the mechanisms involved. Eicosanoids. 1990;3:189-199.
13. Spatz M, Stanimirovic D, Bacic F, Uematsu S, McCarron RM. Vasoconstrictive peptides induce endothelin-1 and prostanoids in human cerebromicrovascular endothelium. Am J Physiol. 1994;266(pt 1):C654-C660.
14. 2 in human platelet-rich plasma. J Biol Chem. 1982;257:14847-14853.
15. Salari H, Chan YM, Mast cell mediators stimulate synthesis of arachidonic acid metabolites in macrophages. J Immunol. 1989;142:2821-2827.
16. Katz HR, Raizman MB, Gartner CS, Scott HC, Benson AC, Austen KF. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells. J Immunol. 1992;148:868-871.
17. 2 production and identification of prostaglandin H synthase within canine mast cell granule. Am J Physiol. 1992;263(pt 1):L168-L176.
18. Kaartinen M, Penttila A, Kovanen PT. Mast cells of two types differing in neutral protease composition in the human aortic intima. Demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas. Arterioscler Thromb Vasc Biol. 1994;14:966-972.
19. Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A. 1974;71:1207-1210.
20. Ohshima H, Brouet IM, Bandaletova T, Adachi H, Oguchi S, Iida S, Kurashima Y, Morishita Y, Sugiura T, Esumi H. Polyclonal antibody against an inducible form of nitric oxide synthase purified from the liver of rats treated with Propionibacterium acnes and lipopolysaccharide. Biochem Biophys Res Commun. 1992;187:1291-1297.
21. Nunokawa Y, Ishida N, Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1993;191:89-94.
22. Marchuk D, Drumm M, Saulino A, Collins F. Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res. 1990;19:1154.
23. 2 receptor antagonist on airway smooth muscle in vitro. Br J Pharmacol. 1991;104:585-590.
24. Koide M, Kawahara Y, Nakayama I, Tsuda T, Yokoyama M. Cyclic AMP-elevation agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. J Biol Chem. 1993;268:24959-24966.
25. Imai T, Hirata Y, Kanno K, Marumo F. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J Clin Invest. 1994;93:543-549.
26. 2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci U S A. 1994;91:12168-12172.
27. 2. J Biol Chem. 1983;258:11713-11718.
28. 2 formed in human plasma. Proc Natl Acad Sci U S A. 1984;81:1317-1321.
29. 2 is a ligand for the adipocyte determination factor PPAR γ. Cell. 1995;83:803-812.
30. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell. 1995;83:813-819.
31. Kaartinen M, Penttila A, Kovanen PT. Extracellular mast cell granules carry apolipoprotein B-100-containing lipoproteins into phagocytes in human arterial intima. Functional coupling of exocytosis and phagocytosis in neighboring cells. Arterioscler Thromb Vasc Biol. 1995;15:2047-2054.
32. Kanno K, Hirata Y, Imai T, Marumo F. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension. 1993;22: 34-39.
33. Di Rosa RM, Radomski M, Carnuccio R, S. Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun. 1990;172:1246-1252.
34. 2 formation and characterization of its synthetases in various tissues of adult rats. Arch Biochem Biophys. 1988;260:521-531.
35. Hirata M, Kakizuka A, Aizawa M, Ushikubi F, Narumiya S. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc Natl Acad Sci U S A. 1994;91:11192-11196.
36. Nakayama I, Kawahara Y, Tsuda T, Okuda M, Yokoyama M. Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J Biol Chem. 1994;269:11628-11633.
37. Ali S, Becker MW, Davis MG, Dorn GW. Dissociation of vasocontrictor-stimulated basic fibroblast growth factor expression from hypertrophic growth in cultured vascular smooth muscle cells. Circ Res. 1994;75:836-843.
38. 2 in nuclei. J Pharmacol Exp Ther. 1985;242:306-311.